Stocksigma LogoStocksigma Logo

Vista Pharmaceuticals to Consider Q4 & FY26 Results on 29-May-26

Vista Pharmaceuticals (BSE: 524711) has scheduled a Board of Directors meeting for Fri, 29th May'26. The agenda includes the consideration and approval of

Vista Pharmaceuticals to Consider Q4 & FY26 Results on 29-May-26

Vista Pharmaceuticals Ltd 路 Intimation 路 29 May 2026, 5:30 am

Vista Pharmaceuticals to Consider Q4 & FY26 Results on 29-May-26 Vista Pharmaceuticals (BSE: 524711) has scheduled a Board of Directors meeting for Fri, 29th May'26. The agenda includes the consideration and approval of the audited financial results and the audit report for the quarter and financial year ended 31st Mar'26.

Original exchange filing (PDF)

More announcements from Vista Pharmaceuticals Ltd

All Vista Pharmaceuticals Ltd announcements